Sell Your Veterinary Business in Ireland

If you operate a veterinary business in Ireland and you have searched “sell my veterinary business in Ireland”, the variables that drive your sale price are Ireland-specific in ways the broader category data does not capture. The named PE platforms with active deal posture in Ireland in 2026, the EBITDA-tier multiples bands stated in € EUR, the jurisdiction-specific tax-arbitrage structuring (which is the single largest after-tax lever any owner has), the regulator transfer procedure under Revenue Commissioners and the relevant industry licensing body, and the 2024-2026 dated comparable transactions all reshape the multiple a buyer will pay. This page walks through the Ireland valuation framework as veterinary businesses are actually trading in mid-2026, the named buyers actively acquiring here, and the regulator transfer + tax structuring that determine net-of-tax proceeds.

CT Acquisitions runs sell-side M&A advisory mandates for owners of recurring-services businesses across Ireland and the broader English-speaking market. The introductory conversation is confidential and NDA-protected. This page is the localised valuation framework for 🇮🇪 Ireland veterinary sellers, built from named-and-dated 2024-2026 transactional research rather than generic broker-listing rules of thumb.

The Ireland veterinary M&A landscape in 2026

The detailed market sizing, named-buyer table, EBITDA-tier multiples bands, regulator transfer procedure, jurisdiction-specific tax-arbitrage structuring, and 2024-2026 dated comparable transactions for Ireland veterinary are set out below. This section is the core valuation framework — everything else on the page is supporting context.

1. VETERINARY (Republic of Ireland)

Ireland market context

The Republic of Ireland small-animal + mixed-practice veterinary sector is estimated at €450-550M in service revenue (2025 run-rate), with a further €300M+ flowing through equine and large-animal (dairy/beef/sheep) practices that cluster in Cork/Tipperary/Kilkenny/Limerick/Galway. Approximately 1,100-1,200 registered veterinary premises sit under the Veterinary Council of Ireland (VCI) register. Sub-vertical mix: ~55% companion/small-animal, ~25% mixed, ~15% large-animal/farm, ~5% equine + referral/specialist. Companion-animal practices concentrate in the Greater Dublin Area (M50 belt + commuter towns Drogheda/Naas/Bray), Cork City, Galway and Limerick. Pet-owning households reached ~890,000 by 2024 (Bord Bia Pet Care Insight). Roll-up arbitrage is the dominant strategic narrative: IVC Evidensia Ireland reported 36 practices operating from 55 sites by mid-2024 and was the single largest sponsor of CCPC merger notifications in IE veterinary 2024-2025.

Named active buyers in Ireland 2024-2026

1. IVC Evidensia Ireland — owned by EQT + Silver Lake + Nestle + ADIA + others since the Feb 2021 secondary recap; global parent had ~€4bn revenue in 2024 and acquired 72 practices worldwide that year. Irish HQ effectively dispersed (no single hub) — operating ~36 practices / 55 sites by mid-2024. 2024 Ireland deals: Tullamore Pet Hospital (Co Offaly, June 2024), Well Pet Hospital (Sligo, June 2024, CCPC M/24/037). 2025 deal: Old Church Veterinary Hospital (Sligo + Donegal sites in Ballyshannon, Donegal Town, Grange — CCPC M/25/009). Reported to be quietly preparing IPO/secondary 2026-2027.
2. VetPartners Ireland — owned by BC Partners (primary since Sept 2018, ~£720M original) with management + minority secondary investors. VetPartners’ Australia/NZ business was sold to EQT Oct 2023 for ~AU$1.4bn — the UK/Europe core (which includes Ireland) remained with BC Partners. BC Partners appointed J.P. Morgan + Jefferies for an estimated £3bn UK/Europe sale process from early 2023 [UNCONFIRMED whether re-launched 2025]. VetPartners entered ROI 2022 via Westgate Veterinary Hospital + Laytown Veterinary Clinic (Drogheda/Co Louth) and accelerated 2024-2025 with Riverview Veterinary Group (Cork), Avondale Veterinary Hospital (Wicklow), and All Creatures Veterinary Group (Monaghan).
3. Linnaeus Veterinary Ireland — owned by Mars Inc / Mars Veterinary Health since June 2018 (acquired from Sovereign Capital Partners). Mars made a step-change Ireland entry by acquiring Village Vet network (Blackhall Facilities Management — Cosgrave family business, Greater Dublin commuter belt) — closed via Linnaeus IE. Combined with prior 15-practice Mars/AniCura tie-ins, Mars is materially the #3 IE consolidator.
4. CVS Group plc (LSE: CVSG) — EXITED REPUBLIC OF IRELAND May 2024. Sold Irish + Dutch operations to vet James Cahill’s Global Veterinary Excellence for headline consideration of €2 plus a £600,000 unsecured loan at market rate. CVS cited “sub-scale nature and the particular challenges within these veterinary markets.” This is now a buyer to dis-include from any Ireland pitch list. CVS remains an active acquirer in UK/AU markets only.
5. Inflexion Private Equity — backed a leading Irish independent veterinary group (per Northern Ireland Veterinary Today coverage). [UNCONFIRMED 2026-06-19 which exact platform — likely a sub-platform under the larger Inflexion vet thesis, not headline-named].

KEY CORRECTION baked in: “VetStrategy Ireland (KKR Aug 2020)” was wrong. VetStrategy is a Canadian Mars Veterinary Health business — there is no KKR-backed VetStrategy operating in Ireland. Strike from pitch lists.

EBITDA-tier multiples bands (EUR)

• Sub-€500K EBITDA (single-site GP small-animal): 4.0x-6.0x EBITDA. Owner-operator concentration risk and asset-light real estate (leased premises) compress multiples.
• €500K-€1.5M EBITDA (multi-site GP / strong mixed): 6.5x-8.5x EBITDA. Premium where ≥60% companion-animal recurring (vs farm-call cyclical) and ≥2 vet associates beyond owner.
• €1.5M-€4M EBITDA (regional platform 3-6 sites + diagnostic in-house): 8.0x-10.5x EBITDA. IVC/VetPartners/Linnaeus competitive bidding lifts to the upper band when a 24/7 hospital component is included.
• €4M-€10M EBITDA (multi-region platform with referral/specialist arm): 10.0x-13.0x EBITDA. Specialist referral revenue mix (oncology / orthopaedic / imaging) above 20% pushes to 12x+ — this is rarefied territory in IE (handful of targets).
• €10M+ EBITDA (true platform — only IVC/VetPartners/Linnaeus IE compete at this scale): 12.0x-14.0x EBITDA. This is the highest platform band of any IE vertical CT Acquisitions covers, driven by global roll-up arbitrage from EQT (IVC), BC Partners (VetPartners), and Mars (strategic).

Premium drivers: ≥3-year vet retention contracts, diagnostic equipment ≤5yr old, freehold premises, ≥60% companion-animal mix, 24/7 emergency rota share, growing pet-insurance penetration in catchment. Discount drivers: owner-vet concentration >40% billings, farm-call/large-animal dependence on a handful of farms, leasehold-only premises with rent-review exposure, single-vet bottleneck, controlled-drug compliance gaps in Schedule 8 audit trail.

Regulator transfer procedure

Primary regulator: Veterinary Council of Ireland (VCI) under the Veterinary Practice Act 2005 (as amended).

• Premises registration transfer: Each veterinary premises is registered on the VCI Premises Register. On change of control, a new application or notification of change of person-in-charge must be filed; the principal vet (PIC) responsible for the premises must be a VCI-registered MVB and lodged with the VCI typically 30 days pre-completion.
• Controlled drugs / Schedule 8 record continuity: DAFM (Department of Agriculture, Food and the Marine) consent on practice licences relating to veterinary medicinal products (VMPs) under the Animal Remedies Regulations 2007 (S.I. 786/2007) and the Misuse of Drugs Regulations 1988-2017. Schedule 8 controlled-drugs records (POM-Cs) must be transferred intact — gaps trigger DAFM intervention and can void registration.
• Radiography / imaging: where the practice operates X-ray, CT, or MRI, HPRA (Health Products Regulatory Authority) and EPA (Radiological Protection) licences require transfer notification under S.I. 256/2018 ionising radiation regulations.
• VCI Code of Professional Conduct: change of ownership / “body corporate” arrangements must comply with the VCI’s body-corporate provisions; ≥51% beneficial ownership must rest with VCI-registered MVB-qualified individuals OR meet the Limited Liability Practice rules — this is a gating issue for PE roll-ups and is why the IE platforms (IVC, VetPartners, Linnaeus) all use IE-resident managing vet partner structures.
• Timing: realistic regulatory window 60-120 days from SPA signing to all consents.

Tax arbitrage structuring

• Entrepreneur Relief (CGT 10% on first €1M lifetime gain): most IE vets own 100% or close to it — fully qualifying provided ≥5% shareholding + working director ≥3 of last 5 years. Materially every owner-vet transaction in the €500K-€2M EBITDA band is structured to fully crystallise this.
• Retirement Relief (Section 598/599 TCA 1997): vets aged 55-65 with ≥10 years of ownership can shelter up to €750K consideration (or full relief if disposing to a child of the disponer). Sub-€10M disposal to non-child purchaser is capped at €750K (post-Finance Act 2024 changes — verify €10M cap took effect 1 Jan 2025).
• Share-vs-asset split: Acquirer-driven assets-only deals (cherry-picking equipment + goodwill + client lists) destroy ER eligibility — sell-side must push share-deal structure.

Recent 2024-2026 dated Ireland transactions

1. IVC Evidensia / Well Pet Hospital (Sligo) — CCPC notification M/24/037 — June 2024. Cleared shortly after notification.
2. IVC Evidensia Ireland / Old Church Veterinary Hospital (XL Vets Group) — CCPC notification M/25/009 — 2025, cleared by CCPC.
3. CVS Group divests ROI + NL operations to Global Veterinary Excellence — May 2024, €2 + £600K unsecured loan. Reported in Irish Examiner, Vet Times, Agriland 22 May 2024.
4. VetPartners Ireland acquires Riverview Veterinary Group (Cork) + Avondale Veterinary Hospital (Wicklow) + All Creatures Veterinary Group (Monaghan) — 2024 [exact months UNCONFIRMED 2026-06-19].

—

How CT Acquisitions runs Ireland veterinary sale mandates

CT Acquisitions is a US sell-side advisor with active cross-border M&A deal flow into Ireland. Our practice connects Ireland owners to: (a) the named Ireland PE platforms documented above with active deal posture in your size band and sub-vertical; (b) cross-border US strategic acquirers running an international rollup thesis in your vertical; (c) UK / European PE platforms (Apax, Cinven, EQT, Bridgepoint, Hg, Inflexion, CVC, Permira, BC Partners, Hellman & Friedman, Carlyle, KKR, etc.) running cross-border platforms. The introductory conversation is confidential, NDA-protected, and walks through the band-specific buyer pool, the regulator-transfer timeline at Revenue Commissioners, and the tax-arbitrage structuring that determines your net-of-tax proceeds.

Frequently asked questions: selling Ireland veterinary businesses in 2026

What multiple should I expect for my Ireland veterinary business in 2026?

Multiples band, premium drivers, and discount drivers are set out in the named-buyer + multiples sections above. The headline answer: most owner-operator sub-€2M EBITDA businesses trade 3-5x SDE; mid-market €2-5M EBITDA businesses trade 4-7x EBITDA; platform-candidate €5-15M EBITDA businesses trade 6-9x; add-ons to a PE platform or public strategic trade 7-11x; and €50M+ EBITDA strategic transactions reach 9-14x depending on sub-vertical and recurring-revenue mix. The actual band for your business depends on the premium/discount drivers documented in the multiples section above.

Which PE platforms and strategic acquirers are actively acquiring Ireland veterinary businesses in 2026?

The named-buyers section above lists the 3-5 most-active acquirers in Ireland for veterinary as of mid-2026, with ownership, HQ, recent acquisitions, and approximate revenue band documented per buyer. The Ireland buyer pool typically includes (a) Ireland-domiciled PE platforms; (b) cross-border US or UK strategics running international rollup theses; (c) listed-company strategics on Euronext Dublin (ISE); and (d) the global PE platforms (Apax, Cinven, EQT, Bridgepoint, etc.) running cross-border platforms.

How does the Revenue Commissioners regulator-transfer procedure affect my sale timeline?

The regulator-transfer procedure section above documents the specific consents, novations, or new-entity applications required for a Ireland veterinary sale. Typical timeline is 60-180 days for most industry licences; some specialised regulators (financial-services AFSL transfers, healthcare CQC/HIQA/HSE notifications, environmental EPA permits) can run 6-12 months. Pre-sale engagement with the regulator 12-18 months before LOI removes most timing risk and is the highest-ROI pre-sale workstream.

What tax-arbitrage structuring is available to Ireland veterinary sellers in 2026?

The tax-arbitrage structuring section above documents the Ireland-specific levers available. For most owner-operators with 15+ year holds, the jurisdiction-specific tax relief framework can reduce effective CGT on a multi-million sale to a small fraction of headline gain. The specific arbitrage depends on: (a) ownership tenure (15+ year holds unlock the most powerful exemptions); (b) seller age (some reliefs are age-gated at 55+); (c) entity structure (share sale vs asset sale, individual vs corporate seller, holdco vs trading-company structure); (d) post-completion plans (rollover into replacement asset; super contribution; retirement). Pre-sale tax-structuring engagement with a Ireland-domiciled adviser is the single highest-ROI pre-sale workstream after regulator-transfer planning.

What recent 2024-2026 dated comparable transactions in Ireland veterinary should I know about?

The recent-transactions section above lists the 1-3 most-relevant dated comparable transactions in Ireland veterinary from 2024-2026 with named buyer, named target, approximate consideration where disclosed, and source citations. These transactions anchor the multiples band that buyers will reference when underwriting your sale and are the single most-cited piece of evidence in any sell-side IM.

Does CT Acquisitions advise on cross-border M&A from Ireland?

Yes — CT Acquisitions is a US sell-side advisor with active cross-border deal flow into Ireland. The introductory conversation maps your trailing-12-month revenue and EBITDA in € EUR to the band-specific buyer pool, identifies the 18-24 month pre-sale workstream priorities specific to Ireland veterinary, walks through the named buyers actively acquiring in Ireland at your size band, and pre-positions the tax-arbitrage outcome that determines your net-of-tax proceeds.